SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " ETA " 10,522 found 🔀 AI-powered Shuffle
PENN Entertainment Inc (PENN) Q3 2026 Earnings Call Highlights: Record Retail Revenue, Raised ...
PENN Entertainment Inc (PENN) posts a record third-quarter with retail revenue of $1.5 billion, lifts full-year 2026 guidance, and signals that interactive losses are largely in the rearview mirror.
Brookdale Science Monday Explores New Technologies Protecting New Jersey’s Endangered Species
Brookdale Science Monday Explores New Technologies Protecting New Jersey’s Endangered Species Free November 23 lecture highlights innovative conservation efforts to protect the state’s most vulnerable wildlife How can cutting-edge technology help save New Jersey’s endangered
America’s Election Has Prompted Some Surprising Moves in Israel That Might Oust Netanyahu
This kind of coalition has happened only once before.
Samsung's over-ear headphones said to be called Galaxy Studio, design details surface
The headphones are expected to rival Sony’s WH-1000XM6 and Apple’s AirPods Max 2. Samsung’s rumored high-end over-ear headphones, reportedly called Galaxy...
Stare Straight Into Your Subject's Soul With This Strange New Camera
Different is... good?
Disney staffers join team meeting, press managers for layoff details
Disney staffers pushed management for answers about reports of layoffs in a tech town hall. Employees say morale is suffering.
Register Now! Webinar on Microplastics: Science, Regulation, and Legal Risk | Retail & Consumer Products Law Observer
Join Crowell & Moring partners Pete Condron and Monty Cooper as they explore the evolving science, regulation, and litigation surrounding
Escape Artist Octopuses Can Squeeze Through Impossibly Small Holes. Now, Scientists Have Figured Out How They Do It
And how their escapology skills could inspire a new era of OctoBots.
Brown fat may benefit cardiovascular, psychiatric health
Researchers found brown fat activity was linked to lower odds of cardiometabolic and psychiatric diseases in humans.
Vance takes aim at Netanyahu over Iran in early 2028 political play, expert says
JD Vance uses clash with Benjamin Netanyahu to distance from Iran war without directly criticizing Trump, Middle East Institute's Natan Sachs says.
"I Am the Creator of the 28-3 Meme" | The Story Behind the Greatest Sports Meme of All Time
Patriots senior content manager Mike Dussault details the story of how he created the infamous 28-3 meme & merchandise following the Patriots epic Super Bowl LI comeback against the Atlanta Falcons.
Snacks sold in California may contain metal, prompting recall. See health risks
High exposure to the metal can potentially cause nerve damage and hair loss, the FDA says.
iOS 27.3 changes the iPhone Duo keyboard, here’s how
The iOS 27.3 beta introduced this week brings a convenient change to the iPhone Duo’s outer display keyboard.
Meta says US users can now video chat with their Muse AI avatar
Meta's AI agent can now take calls as a customizable animated avatar, ahead of the launch of a Tamagotchi-like wearable designed to bring Muse to life.
Rep. DelBene says Democrats will focus on costs, health care after retaking House
US Rep. Suzan DelBene says Democrats plan to make affordability and health care priorities when they take control of the House in January, after voters gave the
Sony Pictures Home Entertainment to Release Horror Thriller 'Crawlers' Digitally Nov. 10, Disc Dec. 22
Sony Pictures Home Entertainment, together with Saban Films, Nov. 5 announced the retail release of horror thriller Crawlers on digital retail platforms on Nov. 10, and on packaged media Dec. 22. The movie generated more than $1.1 million at the global box office, including $688,000 across North American screens. In the movie, a catastrophic infestation … Continue reading "Sony Pictures Home Entertainment to Release Horror Thriller ‘Crawlers’ Digitally Nov. 10, Disc Dec. 22"
First iOS 27.3 and macOS Golden Gate 27.3 Public Betas Now Available
Apple today seeded the first betas of iOS 27.3, iPadOS 27.3, macOS Golden Gate 27.3, tvOS 27.3, and watchOS 27.3. The new software comes two days after Apple released the betas for developers. iOS 27.3 is a major update that adds a Vertical Tabs layout option and Adaptive Dark Mode for Safari. Siri AI can do more in and across Apple's apps, and developers are now able to create actions for Siri to carry out.
Apple releases first iOS 27.3 public beta with redesigned Health app and more
Apple has released the first iOS 27.3 public beta for iPhone. The update brings back the redesigned Health app that...
Exclusive | General Mills Considers Sale of Häagen-Dazs Ice Cream Outside North America
Planning is at an early stage and General Mills, best known for such brands as Cheerios and Lucky Charms, could ultimately retain the business, according to people familiar with the matter.
How Democrats’ midterm gains could reshape the political landscape for AI
Democratic midterm wins could increase scrutiny of AI data centers and power demand, but President Donald Trump retains veto power over any federal legislation.
Trump stands by Hegseth after election losses, but other Republicans want him out
The U.S. defense secretary is facing intense political backlash over the costly and unpopular war with Iran, which the president acknowledged was partly to blame for the drubbing that the GOP took in ...
Volunteers Took Cold Showers For A 12-Week Experiment, And The Results Make Us Want To Give It A Try
I'm going to brace myself and probably scream a little, but perhaps the discomfort will be worth it.
Medicus Pharma proposes $135M SkinJect spinout through SPAC business combination
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to discuss a proposed transaction involving the company's wholly owned subsidiary, SkinJect, which has entered into a non-binding letter of intent with an undisclosed special purpose acquisition company (SPAC) for a potential business combination. The proposed transaction contemplates a US$135 million pre-money enterprise valuation for SkinJect, alongside a concurrent equity financing intended to support the company's SKNJCT-005 clinical study in patients with Gorlin syndrome and preparations for a potential New Drug Application (NDA). Bokhari told Proactive that the proposed deal is designed to establish SkinJect as a separately listed company focused on advancing its dermatology and rare-disease development program. Under the proposed structure, the SPAC would acquire 100% of SkinJect in exchange for newly issued common shares in the combined company. Medicus Pharma intends to retain majority economic and voting ownership, allowing existing Medicus shareholders to maintain significant participation in SkinJect's potential future value. The separation would also provide SkinJect with a dedicated financing platform to fund its clinical development activities, particularly the SKNJCT-005 study targeting Gorlin syndrome, a rare genetic condition associated with the development of multiple basal cell carcinomas. The concurrent financing is expected to support the clinical program and the work required to prepare and potentially submit a New Drug Application, subject to successful development and regulatory progress. Final ownership percentages have not yet been determined. These will depend on negotiations surrounding the definitive transaction agreement and the combined company's capitalization, including retained SPAC cash, public and sponsor shares, warrants and other potentially dilutive securities. Medicus said the proposed transaction remains subject to the completion of definitive documentation and other customary conditions. The planned spinout represents a strategic step in Medicus Pharma's efforts to give SkinJect a dedicated corporate and financial structure, while allowing the parent company to retain majority participation as the dermatology program advances towards its next clinical and regulatory milestones. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #SkinJect #Biotechnology #Healthcare #RareDisease #GorlinSyndrome #Dermatology #SPAC #ClinicalTrials #DrugDevelopment #NDA #Biopharmaceuticals
UK Veterinary Science Marks Opening of the Sports Medicine Research Center
This industry-supported facility will help enable research on musculoskeletal conditions to improve the health and welfare of both horses and humans.
Instagram launches Edits for Mac with multi-track video editing and 4K exports
Instagram users can now download a Mac version of Edits, the company’s free video editing app. Here are the details.
Instagram brings Edits to desktop to take on CapCut
The move puts Edits in more direct competition with ByteDance's CapCut, the video-editing app Meta sought to challenge when it launched Edits last year.
Cleveland Fed’s Hammack says restrictive rates needed to cool inflation
“I expect that monetary policy will need to move to a restrictive stance to bring inflation back to 2% in a timely manner,” Beth Hammack said Thursday, Nov. 5, in remarks prepared for an event in Zurich.
Greenville takes a strategic look at downtown retail
The Greenville City Economic Development Corp. has focused on strategically recruiting new retail stores to downtown Greenville.
Why CVS is breaking up its pharmacy empire now
CVS is splitting off its retail pharmacies as lawmakers intensify scrutiny of vertically integrated insurers, PBMs and pharmacy owners.
Why CVS is breaking up its pharmacy empire now
CVS is splitting off its retail pharmacies as lawmakers intensify scrutiny of vertically integrated insurers, PBMs and pharmacy owners.
Octo Health Launches Beta to Make Proactive, Personalized Healthcare More Accessible
Octo Health brings medical records, lab results, medications and health data into one health timeline, giving consumers a more complete picture of their healthBy combining annual testing of more than 100 biomarkers with unified health data, the platform helps members identify patterns and track health trends over timeAs consumers take a more active role in managing their health, Octo Health gives them greater ownership of their data and helps them understand what it means NEW YORK, Nov. 05, 2026
In brief: 'A Proud Family Wizmas' trailer and more
Zoo wee mama, indeed. There's a brand-new trailer for the upcoming Disney+ animated holiday comedy film Diary of a Wimpy Kid Christmas: The Getaway. Readers of Jeff Kinney’s bestselling book series can see the Heffley family come to life in this festive film that premieres on Dec. 4 ...Speaking of trailers for holiday specials, fans of The Proud Family can watch a brand-new look at the upcoming stop-motion holiday special A Proud Family Wizmas. It arrives on Disney+ Nov. 14. The special is filled with songs and follows Penny Proud as she accidentally destroys Christmas and sets out to make things right. Kyla Pratt returns to voice Penny while guest stars Anderson .Paak, Lil Rel Howery, JB Smoove and Gabrielle Union come along for the ride ... TNCMS.AdManager.render({region: 'fixed-big-ad-top-asset', slot: 1, fold: "above"}); Camila Mendes is back in character as Ana Santos. The actress once again stars as the character in the new sequel film Upgraded 2. Prime Video has announced cameras are up and rolling on the movie in Venice, Italy ...Copyright © 2026, ABC Audio. All rights reserved. Thank you for reading kmaland.comAt KMA, we attempt to be accurate in our reporting. If you see a typo or mistake in a story, please contact us by emailing kmaradio@kmaland.com.
What CVS Health (CVS) Said on Its Q3 Earnings Call
CVS Health (NYSE:CVS) plans to separate its retail pharmacy operations from its insurance and pharmacy services businesses, creating two publicly traded companies in a transaction expected to close in the first half of 2028. The announcement came as the company reported third-quarter 2026 revenue o
Lucky Strike Entertainment Q1 revenue beats estimates; suspends dividend to cut debt
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Clemson University alumnus, business school namesake dies
FOX Carolina's Margaret-Ann Carter has the details.
Mars’s Volcanoes May Not Be Dead But Merely Sleeping. Could A Volcano Erupt On Mars Someday?
After at least 2 million years without an eruption, you might be forgiven for thinking Martian volcanism is dead, but that’s a brief nap to a planet.
Zac Taylor Details DJ Turner, Cedric Johnson's Health After Team Arrival in Spain
Cincinnati is settled in Spain.
Kamala Harris urges Dems to 'be ruthless' with power after midterms, demands Trump accountability
Former Vice President Kamala Harris, former Secretary of State Hillary Clinton, and former President Bill Clinton offered their thoughts on the heels of the midterm elections.
Holiday retail jobs are moving away from the sales floor
Americans are still buying plenty of stuff for the holidays, but they're getting more of it online. That calls for a shift in staffing.
Video: Democratic Health Professionals Win Seats in Congress
Some Democratic doctors and nurses ran and won congressional seats by centering their campaigns on opposing Health Secretary Robert F. Kennedy Jr.
When papers become currency: a Chinese debate about trust in science
Last Saturday, 31 October, I went to the University of Hong Kong’s Beijing Centre for its Talent Forum. It was the fourth stop in the series this year, following events in Shanghai’s Zhangjiang, Shenzhen’s Qianhai, and on HKU’s main campus. The programme covered a remarkable distance in one afternoon. HKU’s Xiao-Jing Wang discussed computational neuroscience, intelligence, and the prefrontal cortex—before even delivering his inaugural public lecture to students back in Hong Kong. His colleague Bing Zhang took us from the Big Bang to artificial intelligence. Tsinghua’s Xue Lan asked how AI might reshape the institutional infrastructure underpinning higher education. There were lively panels featuring industry leaders from JD.com, Xiaomi, Haier—and Kaiser Y Kuo on the closing panel discussing innovation and international connections. I cannot pretend to have followed every detail of the brain models or the astrophysics. The talk that stayed with me was closer to something we have covered before: Zhou Zhonghe 周忠和 on papers, evaluation, and scientific trust. Zhou is a palaeontologist, an Academician of the Chinese Academy of Sciences, and an international member of the US National Academy of Sciences. He is also editor-in-chief of The Intellectual (知识分子), China’s leading science commentary platform. His subject was uncomfortable enough for a room full of successful academics: what happens when the system for recognising good science starts rewarding something else? Part of my interest came from our sister newsletter, The East is Read, which covered the controversy around “Geng Tongxue” in May. A PhD dropout from Beihang University, Geng has publicly challenged papers by prominent researchers through detailed online allegations of manipulated images and fabricated data. At Tongji University, an investigation into a challenged Nature paper found academic misconduct, and the dean of its life sciences school was removed. The affair brought doubts about academic integrity well beyond laboratories and university committees. How could someone outside the established hierarchy spot problems in papers that had passed through prestigious journals and institutions? And what, exactly, had all that prestige guaranteed? Zhou approached these questions through two essays published in July by The Intellectual: one by Wang Xiaodong, director of the National Institute of Biological Sciences, Beijing, and a response by Wang Liming, of Shanghai’s Shangsi Institute of Natural Sciences. Both began with the controversy over Geng. Their arguments deserve a wider audience, so I want to put parts of them alongside what Zhou said on Saturday. Wang Xiaodong’s starting point is evolution. A research system selects for the behaviour it rewards. Grants, jobs, journals, talent programmes, and prizes collectively determine which scientists prosper and which practices get passed down from advisors to students. “Whatever the system rewards is what it will evolve to produce,” he writes, citing the ancient Chinese saying: The King of Chu loved slender waists, and many in the palace starved to death. That is a more demanding diagnosis than saying there are dishonest people in science. Punishing a fraudster does not change the selective environment that made a particular kind of research profitable. His account also gives scientific success an awkward role in the story. As Zhou put it on Saturday, science became a victim of its own success. Once research became central to industry, national power, and economic growth, universities and laboratories expanded, and public money followed. That created an administrative need for rapid decisions: who should get the next grant, the next laboratory, the next appointment? The difficulty is that the true value of a discovery may take years or decades of testing and building to become clear. Resource allocation cannot wait that long. Publication counts, journal prestige, impact factors, and citations therefore become convenient ways to make an instant judgement. “The real problem is not that these indicators have no value,” Wang Xiaodong writes, “but that they are trying to answer a question that only time can answer.” Telling administrators simply to stop counting papers will never be enough. They still have budgets to distribute and appointments to make. Something has to replace the shortcut. Zhou described the consequences inside publishing. Papers acquire ever more requirements: a complete story, polished presentation, extensive datasets, and accessibility to readers beyond the immediate field. Individually, those demands sound reasonable. Together, he warned, they produce formulaic “eight-legged” papers 八股文 and rigid reviewing, while genuinely original or non-consensus work struggles to get past journal editors—some of whom wield immense gatekeeping power despite having limited laboratory experience themselves. Meanwhile, the demands for sprawling, “complete” narratives have fuelled a wider replication crisis. Wang Xiaodong uses a mahjong metaphor to describe the result: put the complex papers published by the exact same lab over several years side by side, and they often look like “Thirteen Orphans” (十三不靠)—every tile completely unrelated to the next, and none of them reproducible by outsiders. Zhou also spoke frankly as an editor who has trouble finding reviewers. Everyone wants someone else to review their work; qualified senior researchers have little time to return the favour. The labour is anonymous, unpaid, and brings almost no institutional recognition, so it increasingly gets passed down to postdocs and graduate students. And while anonymity protects reviewers from rank and personal favours, hyper-specialisation means an author’s most qualified reviewer is often a direct competitor, shielded from accountability. The protection and the problem coexist. Wang Liming takes the argument a step further. The decisive change, in his essay, is the instant conversion of academic honour into material resources. Once a paper can be cashed in for funding, a job, students, commercial investment, or even a company valuation, scientists are alienated from their work: they must keep minting this “research currency” to keep their teams alive. He is careful not to romanticise the past. The old world of gentleman scientists—financially independent figures like Boyle and Darwin who needed nothing from external funders—was also a closed club that excluded people without inherited wealth, women, and much of humanity outside the West. Professional science allowed ordinary people, himself included, to become researchers. Nobody should want to undo that. The problem, in his account, is an exchange system that becomes too uniform and too difficult to correct. His most pointed Chinese example is the “hat” (帽子): the prestigious talent designation that brings continuing access to money, laboratory space, students, and institutional influence. “If papers are the circulating currency of the research system, then a ‘hat’ is a bond that pays interest over the long term,” he writes. A paper at least requires another round of peer review. A title in the Chinese context can lock in a judgement made years ago and turn it into permanent status rent, regardless of whether its holder is still doing good science. Here, official institutions hire, organise, and evaluate scientists. Unlike honours awarded by autonomous academic communities in the West, a Chinese “hat” blends non-scientist administrative power with state authority. Once granted, it turns a past judgement into permanent status rent that is nearly impossible to revoke—because taking a hat off would imply that official authority erred in putting it on. Both Wangs see China as experiencing, at compressed speed, pressures present across global science. Research expansion, rising investment, publication growth, and elaborate evaluation metrics arrived in China within two or three decades rather than two or three centuries. Zhou agreed with that international framing—noting that recent US White House science policy documents and the new president of the US National Academy of Sciences, a fellow palaeontologist who recently visited Zhou’s institute in Beijing, have raised strikingly similar warnings about consensus-bound peer review, short-term project grants, and the replication crisis. Still, Zhou emphasised that China’s traditional hierarchy, personal networks (guanxi), and the ethos that “a good scholar becomes an official” (学而优则仕) amplify those pressures at home. So what would change things? Here Zhou’s tone differed from the call for a revolution in scientific trust in Wang Xiaodong’s essay. As an evolutionary biologist, Zhou favoured patchwork repair (修修补补). Living systems survive through accumulated adjustments; dramatic mutations are usually fatal. Science cannot return to a small, slow-moving pastoral era, especially after the successive accelerations of professionalisation after the Second World War, the internet, and now artificial intelligence. But it can alter the local environment in which researchers work. He pointed to domestic experiments designed to support unconventional research and diversify funding, including Tencent’s New Cornerstone Investigator Program, the Xplorer Prize, and the Future Science Prize. He also mentioned participating in reviews for “major non-consensus projects” under the National Natural Science Foundation of China. One guiding principle he recalled was wonderfully direct: “Failure is allowed; corruption is not” (允许失败，不允许腐败). That distinction would mean quite a lot if taken seriously. An honest attempt that fails should not have to disguise itself as a success to survive an assessment. Wang Liming’s essay adds a sharp caveat to the optimism about new domestic funders. Multiple organisations do not automatically produce multiple ways of judging science. If the same pool of senior domestic scientists makes the decisions through the same two-round review procedures, it is still “fake diversity.” He argues for three distinct kinds of money: broad baseline funding governed by fair procedures; patient funding for questions that take ten years; and non-consensus funding based on individual taste, deliberately empowering a few genuine experts to make biased, contrarian bets on eccentric ideas that would inevitably be averaged out by a committee. Replacing one monopoly with another achieves little; a healthy ecosystem needs variance. Zhou’s proposals for publishing were similarly concrete: strip papers of their resource-allocation burden and return them to recording discoveries and establishing priority; separate dissemination from evaluation, as eLife and Peer Community In do; adopt more modular “micro-publications” and real-name endorsements; recognize the labour of editors and reviewers; and give replication work proper credit rather than treating it as an unpublishable dead end. AI makes every part of this debate more urgent—and Zhou wove it throughout his talk. In his own preparation, he used AI to survey the declining influence of academic monographs, noting how tools are already changing how scholars gather information. More fundamentally, he placed AI as the latest great acceleration in scientific history: just as the internet sped up the pace of research and tightened external resource pressures, AI is compressing the cycle again. In the essays Zhou cited, AI cuts both ways. Wang Xiaodong expects large language models to erase much of the English-writing disadvantage long faced by Chinese scientists, further swelling the flood of papers coming out of Chinese labs. Wang Liming sees AI accelerating both ends of the trust crisis: it lowers the cost of paper mills and fabricated images just as quickly as it lowers the cost of automated image forensics, data auditing, and code reproduction. “Whoever builds the verification layer wins,” Wang Liming writes. His proposed alternative to the static, packaged “story paper” is a continuously versioned “unit of discovery” containing a falsifiable claim, raw data, analysis code, experimental parameters, and an ongoing log of independent checks—where negative results and failed replications are recorded rather than buried. Zhou ended his keynote by bringing AI back to the question of scientific honour and credit. Citing a recent Intellectual discussion on “What AI Means for Mathematics” featuring Fields Medalist Deng Yu 邓煜—at a moment when AI is already batch-solving mathematical conjectures, as HKU Vice-President Lin Chen noted in his opening remarks—Zhou agreed that human researchers must remain the principal agents: AI is a tool that frees scientists from tedious calculation to think about deeper, messier real-world problems. Yet that partnership creates a thorny new evaluation problem. When a breakthrough is made with AI, what is the human contribution and what is the machine’s? And since AI models distil centuries of accumulated human scholarship, is it right that the credit and value flow so heavily to the private AI companies building the tools? The old struggle over how to assign scientific honour is acquiring a whole new layer. What I took away was a serious discussion of how science can remain trustworthy as its scale, incentives, and tools change. These were scientists with real standing inside China’s system questioning how that standing is produced, and proposing changes that would affect their own institutions and peers. That made the afternoon at HKU’s Beijing Centre worthwhile. At the close, Wang Feng, Director of Communications and Public Affairs at HKU, said the value of the forum series—which heads to Hangzhou in December and cities like Chengdu early next year—would lie in the real cooperation it helped bring about. The university has plenty to celebrate: this week it topped the QS Asia rankings for a second consecutive year, alongside its 11th-place position in the QS World University Rankings 2027. For me, bringing this debate to an audience beyond the people who review papers and allocate grants was a useful contribution. Share [ The East is Read PhD dropout’s exposé forces an academic fraud reckoning in China A former doctoral student turned blogger has shaken China’s academic establishment by publicly accusing prominent university scholars of fabricating data and manipulating papers, triggering investigations at several leading institutions and drawing rare attention from state media… Read more 5 months ago · 43 likes · 8 comments · Yuxuan JIA ](https://www.eastisread.com/p/phd-dropouts-expose-forces-an-academic?utm_source=substack&utm_campaign=post_embed&utm_medium=web&embedding_publication_id=47580)
World Market opens Spokane Valley location
Alameda, California-based World Market LLC has opened its second Spokane-area store, bringing 60 jobs to a 17,000-square-foot retail space, at 15110 E. Indiana in Spokane Valley.
Maro Itoje and the art of sports leadership: ‘It’s not a democracy. It’s a benevolent dictatorship’
England's rugby union captain on learning from Mikel Arteta and what a Samurai sword taught him about motivation
Monolith Soft details its involvement with Zelda: Ocarina of Time remake
Monolith Soft has officially come forward to confirm its involvement with The Legend of Zelda: Ocarina of Time remake on Nintendo Switch 2. The company posted about the news on social media. Monolith Soft says it “handled partial contract development of the game design, programming, and graphics.” Monolith Soft can also be found in the title’s credits. The company is...
Meta President on Data Center Politics
Dina Powell McCormick of Meta tells WSJ editor-in-chief Emma Tucker that a newly elected Governor who ran on a data center platform said "as soon as we get past the inauguration, let's meet, because we don't want to lose this investment."
CVS Health plans to split into two publicly traded companies
CVS Pharmacy would operate 9,000 retail pharmacies; Aetna, CVS Caremark would remain with health care solutions company | Anadolu
Melbourne business owner offers free help to flood-damaged vehicles
A Melbourne detailer is offering free help to flood-damaged vehicles after deadly flooding, and 300 people have already reached out.
Robert F. Kennedy Jr. to visit North Dakota, participate in agriculture, health discussions
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. will visit North Dakota Thursday to participate in three roundtable discussions with state and tribal leaders.
Republicans quickly turn against Pete Hegseth after midterms rout
President Donald Trump may have made the decision to launch the war that tanked voters’ support for the GOP and dealt them a midterm shellacking. But the historic losses are accelerating a push for someone else to take the fall: Defense Secretary Pete Hegseth.
Madueke and Gyokeres goals give Arsenal win in Prague
Arsenal held off a late Slavia Prague fightback to secure a 2-1 Champions League victory in the Czech Republic.Noni Madueke gave Mikel Arteta’s side the perfect start after nine minutes, racing onto...
Emma Thompson’s husband Greg Wise details struggles amid IVF journey: ‘The most authentic feeling of failure’
Emma Thompson’s husband Greg Wise detailed the ‘grief’ they felt throughout their IVF journey.
Five Players Seminoles Need to Retain Amidst Coaching Change
With a coaching new-hire on the horizon, Florida State needs to retain a nucleus of talent.
CVS Health to Split Into 2 Public Companies, Separating Retail and Specialty Pharmacy
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
CVS Health plans retail pharmacy spinoff
CVS Health plans to spin off its retail pharmacy business in one of the biggest-ever breakups in the healthcare industry.
Mapping the hidden hazards beneath our feet | Investors Lab
From unstable slopes to former industrial sites to hurricane alleys, some places are not safe to live in. Yet circumstances often force low-income populations into these areas, where natural disasters can have devastating effects. Rebecca Dzombak fills in the details for SN. And we have intel on advanced imagery and subsurface mapping that aim to provide early warnings before disasters strike.
Democratic doctors win big in 2026 midterm elections
A political action group says Congress now has a new mandate against Health Secretary RFK Jr.
How healthy are your muscles?
Body mechanics experts say skeletal muscle quality is an overlooked vital sign that’s key to longevity and overall health.
Haaland won election. Now, how will she govern?
By Kevin Hendricks — New Mexico made history Tuesday night with Deb Haaland winning her campaign to be the first Native American woman to win a governor’s seat. Haaland, a Laguna Pueblo member and former U.S. Interior secretary, beat Republican Gregg Hull by 14 points to become New Mexico’s next governor. She takes office Jan. […]
UK Veterinary Science Marks Opening of the Sports Medicine Research Center
The new industry-supported facility will advance research on musculoskeletal conditions to improve equine and human health and welfare.
Trump-backed redistricting sought a midterm edge for Republicans. It didn't work
Republicans lost most of the Democratic-held seats they had targeted to flip, lost others they had banked on retaining and got swept out of power by a Democratic surge fueled by voter dissatisfaction with Trump, the economy and the war with Iran.
CVS Health plans to split itself up. Here's why a breakup could make sense now
Analysts say that after a roughly two-year turnaround the company's retail pharmacy business and other units may be strong enough to stand on their own.
CVS Health plans to split itself up. Here's why a breakup could make sense now
Analysts say that after a roughly two-year turnaround the company's retail pharmacy business and other units may be strong enough to stand on their own.
Political analyst details Becerra's outlook as California governor, impact of voter divide on results
Political analyst Mike Luery joined KCRA 3 on Wednesday to share his takeaways about the voting results so far from midterm elections.
CVS plans to break up $117 billion healthcare conglomerate
CVS Health Corp. plans to spin off its retail pharmacy business in one of the biggest-ever breakups in the healthcare industry. The drugstore business will be separated into a new
CVS Health to spin off its retail pharmacies into new company after regulatory pressure
The big announcement was made on Wednesday, and many of the details are still being worked out ahead of the planned 2028 split of the company. For now, the plan is for CVS Health to retain its core Caremark and Aetna businesses, with the pharmacy company to take over prescription drug sales and urgent care services.
U.K. Culture Secretary Scrutinizing Comcast-Owned Sky's Acquisition of ITV Media & Entertainment
U.K. Culture Secretary Lisa Nandy Nov. 4 disclosed that she will look into Comcast-owned Sky’s $2.15 billion acquisition of ITV’s Media & Entertainment, which includes its free-to-air channels and the ITVX streaming platform. In a statement, Nandy, who most-recently conducted an 11th hour investigation of Paramount’s $111 billion merger with Warner Bros. Discovery, says she … Continue reading "U.K. Culture Secretary Scrutinizing Comcast-Owned Sky’s Acquisition of ITV Media & Entertainment"
Judge dismisses most claims in UVA Health lawsuit, allows others alleging workplace retaliation to proceed
The ruling comes a year after the lawsuit was filed and nearly two years after UVA Health faculty raised concerns about patient safety, workplace retaliation and leadership practices.
With iOS 27.3, Apple will start checking iCloud public links for ‘harmful content’
iOS 27.3 makes a change to how public iCloud links work, with the aim of preventing harmful content from being shared. Here are the details.
Israel’s Coalition Politics Are More Complicated Than Identity
The idea that Israel’s Jewish opposition parties can join forces with Arab parties to remove Netanyahu overlooks fundamental disagreements that make such a coalition difficult to form, let alone sustain....
UK government announces public interest investigation into Sky deal to takeover ITV's media arm
U.K. Culture Secretary Lisa Nandy says she will intervene in the planned 1.6 billion-pound or $2.2 billion deal between Sky and ITV’s media and entertainment arm. Nandy said Wednesday that
UK government announces public interest investigation into Sky deal to takeover ITV's media arm
U.K. Culture Secretary Lisa Nandy says she will intervene in the planned 1.6 billion-pound or $2.2 billion deal between Sky and ITV’s media and entertainment arm. Nandy said Wednesday that she will...
Mariners News: Jason Kanzler, Edwin Uceta, and Robinson Canó, Jr.
The Mariners have their new skipper, the Astros search for theirs, and MLB announces another CBA proposal.
CVS confirms it will split pharmacy business from insurance
The 2018 merger of insurance behemoth Aetna and a 9,000-store retail pharmacy chain had built a $117 billion empire.
Israel politicians accuse Netanyahu of being 'danger to Israel,' harming ties with US Democrats
Yair Lapid, who leads the Yesh Atid party, added that the midterm results have ruined any chance of forming a unity government with Netanyahu.
CVS to split into two companies, in major breakup of its $117 billion healthcare empire
CVS Health said Wednesday it is splitting into two companies, marking one of the largest shakeups in the healthcare industry. It’s a major reversal of the mergers that brought together the nation’s largest drugstore retailer along with health insurance giant Aetna and pharmacy benefit manager Caremark.
CVS to split into two companies, in major breakup of its $117 billion healthcare empire
CVS Health said Wednesday it is splitting into two companies, marking one of the largest shakeups in the healthcare industry. It’s a major reversal of the mergers that brought together the nation’s largest drugstore retailer along with health insurance giant Aetna and pharmacy benefit manager Caremark.
Apple May Phase Out Non-Touch High-End MacBook Pros
Apple will likely consolidate its high-end MacBook Pro lineup around touchscreen models, according to Bloomberg's Mark Gurman. Writing in his latest "Power On" newsletter, Gurman questioned whether Apple would keep updating its high-end MacBook Pro models without touchscreens. The company has retained the mini-LED M5 Pro and M5 Max models alongside the new touchscreen versions, which cost $400 more.
Can Meta’s Business Pay For Its Spending?
For questions about this article or underlying research, email help@trefis.com.Management said on its October 21, 2026 call that Meta Platforms (META) is spending heavily on servers, data centers and network infrastructure.
Democrats take full control of Legislature, Michigan government. What to expect
Gov.-elect Jocelyn Benson can expect smooth sailing for her agenda, as Democrats win the state House, grow their Senate majority and maintain control of the Supreme Court, attorney general and secretary of state.
Analysis-AI shopping agents could threaten Amazon and Walmart’s ad business
By Juveria Tabassum, Nicholas P. Brown and Arriana McLymore Nov 4 (Reuters) - The rise of AI-led shopping is posing a conundrum for retailers like Walmart and Amazon: how to enable AI agents to shop on their websites, without threatening their lucrativ...
Analysis-AI shopping agents could threaten Amazon and Walmart’s ad business
By Juveria Tabassum, Nicholas P. Brown and Arriana McLymore Nov 4 (Reuters) - The rise of AI-led shopping is posing a conundrum for retailers like Walmart and Amazon: how to enable AI agents to shop on their websites, without threatening their lucrativ...
Good sleep protects brain health in people with cardiometabolic disease
People with type 2 diabetes, heart disease or stroke who sleep well have better cognitive function and greater brain volume than people with the same conditions who sleep poorly, according to a new study from Karolinska Institutet.